{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:51:18Z","timestamp":1792785078910,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"KI Research Foundation Grants","award":["2024-02353"],"award-info":[{"award-number":["2024-02353"]}]},{"name":"The Swedish Cancer Society","award":["24 0829 PT"],"award-info":[{"award-number":["24 0829 PT"]}],"id":[{"id":"https:\/\/ror.org\/0527jb766","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Swedish Cancer Society","award":["26-5197-IA-SIA"],"award-info":[{"award-number":["26-5197-IA-SIA"]}],"id":[{"id":"https:\/\/ror.org\/0527jb766","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Swedish Cancer Society","award":["23 2843 Pj and 24 0866 SIA"],"award-info":[{"award-number":["23 2843 Pj and 24 0866 SIA"]}],"id":[{"id":"https:\/\/ror.org\/0527jb766","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["TJ2016-0035, PR2016-0019, PR2019-0025, PR2022-0009 and PR2024-0065"],"award-info":[{"award-number":["TJ2016-0035, PR2016-0019, PR2019-0025, PR2022-0009 and PR2024-0065"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Swedish Research Council","award":["2017-01653"],"award-info":[{"award-number":["2017-01653"]}]},{"name":"The Felix Mindus Contribution to Leukemia Research"},{"name":"The Dr. \u00c5ke Olsson Foundation for Hematological Research","award":["2021-00130"],"award-info":[{"award-number":["2021-00130"]}]},{"name":"Cancer Research Foundations of Radiumhemmet","award":["221132 and 241243"],"award-info":[{"award-number":["221132 and 241243"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute lymphoblastic leukemia (ALL) exhibits molecular and metabolic heterogeneity that limits therapeutic efficacy. Although antimetabolites remain central to ALL treatment, determinants of therapeutic sensitivity and resistance remain incompletely understood. Here, we investigated the activity and molecular response landscape of the purine analog triciribine (TCN) across diverse ALL models using integrated phosphoproteomics, thermal proteome profiling, and quantitative proteomics. TCN showed potent cytotoxicity across ALL cell lines and a drug response profile distinct from canonical PI3K\u2013Akt\u2013mTOR inhibitors. Early phosphoproteomics revealed no consistent suppression of Akt pathway signaling, with transient activation of several Akt-associated readouts and inhibition of cyclin-dependent kinase signaling. The monophosphorylated metabolite TCN-P was the predominant intracellular active species, and adenosine kinase (ADK) was required for TCN-P generation and cytotoxicity. Proteome Integral Solubility Alteration profiling identified candidate TCN-P interactions involving nucleotide metabolism, DNA replication, and protein synthesis, associated with impaired purine biosynthesis, DNA damage, translational stress, and cell-cycle perturbation. Across ALL cell lines and primary samples, ADK levels correlated positively with TCN sensitivity, supporting ADK-dependent metabolism as a major determinant of therapeutic response. Together, these findings identify TCN as a metabolically activated antileukemic agent with broad antimetabolite activity and nominate ADK as a potential predictive biomarker for precision therapy in ALL.<\/jats:p>","DOI":"10.1038\/s41698-026-01736-z","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:36:36Z","timestamp":1792042596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics profiling identifies triciribine as a biomarker-guided antimetabolite therapy for acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2659-309X","authenticated-orcid":false,"given":"Xuekang","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mermelekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8307-9575","authenticated-orcid":false,"given":"Ondrej","family":"Hodek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luay","family":"Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Glaziou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Rose","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-0753","authenticated-orcid":false,"given":"Nona","family":"Struyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke M.","family":"Hormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Siavelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-4153","authenticated-orcid":false,"given":"Henri Colyn","family":"Bwanika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3623-9569","authenticated-orcid":false,"given":"Owen F. J.","family":"Hovey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Haraldsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean G.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika I.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Erkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja Pokrovskaja","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Lehti\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozbeh","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"1736_CR1","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard, F. & Mohty, M. Acute lymphoblastic leukaemia. Lancet 395, 1146\u20131162 https:\/\/doi.org\/10.1016\/S0140-6736(19)33018-1 (2020).","journal-title":"Lancet"},{"key":"1736_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","volume":"10","author":"L Pagliaro","year":"2024","unstructured":"Pagliaro, L. et al. Acute lymphoblastic leukaemia. Nat. Rev. Dis. Prim. 10, 41 https:\/\/doi.org\/10.1038\/s41572-024-00525-x (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1736_CR3","doi-asserted-by":"publisher","first-page":"e2423169122","DOI":"10.1073\/pnas.2423169122","volume":"122","author":"JY Wang","year":"2025","unstructured":"Wang, J. Y. et al. Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 122, e2423169122 https:\/\/doi.org\/10.1073\/pnas.2423169122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1736_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen, N. J. & Singh, P. K. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat. Rev. Cancer 23, 275\u2013294 https:\/\/doi.org\/10.1038\/s41568-023-00557-7 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"1736_CR5","doi-asserted-by":"publisher","unstructured":"Chandel, N. S. Nucleotide metabolism. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a040592 (2021).","DOI":"10.1101\/cshperspect.a040592"},{"key":"1736_CR6","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1016\/j.cell.2024.05.011","volume":"187","author":"DH Tran","year":"2024","unstructured":"Tran, D. H. et al. De novo and salvage purine synthesis pathways across tissues and tumors. Cell 187, 3602\u20133618 e3620 https:\/\/doi.org\/10.1016\/j.cell.2024.05.011 (2024).","journal-title":"Cell"},{"key":"1736_CR7","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41375-022-01591-4","volume":"36","author":"LN Toksvang","year":"2022","unstructured":"Toksvang, L. N., Lee, S. H. R., Yang, J. J. & Schmiegelow, K. Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations. Leukemia 36, 1749\u20131758 https:\/\/doi.org\/10.1038\/s41375-022-01591-4 (2022).","journal-title":"Leukemia"},{"key":"1736_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/s1470-2045(02)00788-x","volume":"3","author":"CM Galmarini","year":"2002","unstructured":"Galmarini, C. M., Mackey, J. R. & Dumontet, C. Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol. 3, 415\u2013424 https:\/\/doi.org\/10.1016\/s1470-2045(02)00788-x (2002).","journal-title":"Lancet Oncol."},{"key":"1736_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00280-023-04562-3","volume":"92","author":"SG Rudd","year":"2023","unstructured":"Rudd, S. G. Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities. Cancer Chemother. Pharm. 92, 241\u2013251 https:\/\/doi.org\/10.1007\/s00280-023-04562-3 (2023).","journal-title":"Cancer Chemother. Pharm."},{"key":"1736_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41375-025-02529-2","volume":"39","author":"FM Hormann","year":"2025","unstructured":"Hormann, F. M. & Rudd, S. G. Nelarabine in T-cell acute lymphoblastic leukemia: intracellular metabolism and molecular mode-of-action. Leukemia 39, 531\u2013542 https:\/\/doi.org\/10.1038\/s41375-025-02529-2 (2025).","journal-title":"Leukemia"},{"key":"1736_CR11","first-page":"491","volume":"70","author":"LL Wotring","year":"1986","unstructured":"Wotring, L. L., Crabtree, G. W., Edwards, N. L., Parks, R. E. Jr. & Townsend, L. B. Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCN. Cancer Treat. Rep. 70, 491\u2013497 (1986).","journal-title":"Cancer Treat. Rep."},{"key":"1736_CR12","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/jnci\/57.6.1283","volume":"57","author":"PG Plagemann","year":"1976","unstructured":"Plagemann, P. G. Transport, phosphorylation, and toxicity of a tricyclic nucleoside in cultured Novikoff rat hepatoma cells and other cell lines and relase of its monophosphate by the cells. J. Natl. Cancer Inst. 57, 1283\u20131295 https:\/\/doi.org\/10.1093\/jnci\/57.6.1283 (1976).","journal-title":"J. Natl. Cancer Inst."},{"key":"1736_CR13","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1016\/0006-2952(89)90684-9","volume":"38","author":"EC Moore","year":"1989","unstructured":"Moore, E. C., Hurlbert, R. B. & Massia, S. P. Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis. Biochem. Pharm. 38, 4037\u20134044 https:\/\/doi.org\/10.1016\/0006-2952(89)90684-9 (1989).","journal-title":"Biochem. Pharm."},{"key":"1736_CR14","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1089\/aid.1998.14.1315","volume":"14","author":"RG Ptak","year":"1998","unstructured":"Ptak, R. G. et al. Phosphorylation of triciribine is necessary for activity against HIV type 1. AIDS Res Hum. Retroviruses 14, 1315\u20131322 https:\/\/doi.org\/10.1089\/aid.1998.14.1315 (1998).","journal-title":"AIDS Res Hum. Retroviruses"},{"key":"1736_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17336-9","volume":"11","author":"M Frejno","year":"2020","unstructured":"Frejno, M. et al. Proteome activity landscapes of tumor cell lines determine drug responses. Nat. Commun. 11, 3639https:\/\/doi.org\/10.1038\/s41467-020-17336-9 (2020).","journal-title":"Nat. Commun."},{"key":"1736_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1023\/a:1023893700386","volume":"20","author":"K Shedden","year":"2003","unstructured":"Shedden, K., Townsend, L. B., Drach, J. C. & Rosania, G. R. A rational approach to personalized anticancer therapy: chemoinformatic analysis reveals mechanistic gene-drug associations. Pharm. Res. 20, 843\u2013847 https:\/\/doi.org\/10.1023\/a:1023893700386 (2003).","journal-title":"Pharm. Res."},{"key":"1736_CR17","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","volume":"64","author":"L Yang","year":"2004","unstructured":"Yang, L. et al. Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res. 64, 4394\u20134399, https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0343 (2004).","journal-title":"Cancer Res."},{"key":"1736_CR18","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/cdd.2010.63","volume":"17","author":"N Berndt","year":"2010","unstructured":"Berndt, N. et al. The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane. Cell Death Differ. 17, 1795\u20131804 https:\/\/doi.org\/10.1038\/cdd.2010.63 (2010).","journal-title":"Cell Death Differ."},{"key":"1736_CR19","doi-asserted-by":"publisher","first-page":"14379","DOI":"10.1021\/acs.chemrev.6b00209","volume":"116","author":"J Shelton","year":"2016","unstructured":"Shelton, J. et al. Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs. Chem. Rev. 116, 14379\u201314455 https:\/\/doi.org\/10.1021\/acs.chemrev.6b00209 (2016).","journal-title":"Chem. Rev."},{"key":"1736_CR20","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1158\/1078-0432.CCR-06-2837","volume":"13","author":"CH Lu","year":"2007","unstructured":"Lu, C. H. et al. Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency. Clin. Cancer Res. 13, 5883\u20135888 https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2837 (2007).","journal-title":"Clin. Cancer Res."},{"key":"1736_CR21","first-page":"4891","volume":"50","author":"LL Wotring","year":"1990","unstructured":"Wotring, L. L. et al. Dual mechanisms of inhibition of DNA synthesis by triciribine. Cancer Res. 50, 4891\u20134899 (1990).","journal-title":"Cancer Res."},{"key":"1736_CR22","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1016\/0006-2952(89)90685-0","volume":"38","author":"EC Moore","year":"1989","unstructured":"Moore, E. C., Hurlbert, R. B., Boss, G. R. & Massia, S. P. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P). Biochem. Pharm. 38, 4045\u20134051 https:\/\/doi.org\/10.1016\/0006-2952(89)90685-0 (1989).","journal-title":"Biochem. Pharm."},{"key":"1736_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/1120009X.2024.2403050","volume":"37","author":"S Takahashi","year":"2025","unstructured":"Takahashi, S. Signaling effect, combinations, and clinical applications of triciribine. J. Chemother. 37, 494\u2013502 https:\/\/doi.org\/10.1080\/1120009X.2024.2403050 (2025).","journal-title":"J. Chemother."},{"key":"1736_CR24","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.leukres.2013.07.034","volume":"37","author":"D Sampath","year":"2013","unstructured":"Sampath, D. et al. Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies. Leuk. Res. 37, 1461\u20131467 https:\/\/doi.org\/10.1016\/j.leukres.2013.07.034 (2013).","journal-title":"Leuk. Res."},{"key":"1736_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold, R. & Mann, M. Mass-spectrometric exploration of proteome structure and function. Nature 537, 347\u2013355 https:\/\/doi.org\/10.1038\/nature19949 (2016).","journal-title":"Nature"},{"key":"1736_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54654-8","volume":"16","author":"IR Leo","year":"2025","unstructured":"Leo, I. R. et al. Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets. Nat. Commun. 16, 1948 https:\/\/doi.org\/10.1038\/s41467-024-54654-8 (2025).","journal-title":"Nat. Commun."},{"key":"1736_CR27","doi-asserted-by":"publisher","first-page":"1255784","DOI":"10.1126\/science.1255784","volume":"346","author":"MM Savitski","year":"2014","unstructured":"Savitski, M. M. et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science 346, 1255784 https:\/\/doi.org\/10.1126\/science.1255784 (2014).","journal-title":"Science"},{"key":"1736_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41589-023-01284-8","volume":"19","author":"N Kurzawa","year":"2023","unstructured":"Kurzawa, N. et al. Deep thermal profiling for detection of functional proteoform groups. Nat. Chem. Biol. 19, 962\u2013971 https:\/\/doi.org\/10.1038\/s41589-023-01284-8 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"1736_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84\u201387 https:\/\/doi.org\/10.1126\/science.1233606 (2013).","journal-title":"Science"},{"key":"1736_CR30","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1021\/acs.jproteome.9b00500","volume":"18","author":"M Gaetani","year":"2019","unstructured":"Gaetani, M. et al. Proteome integral solubility alteration: a high-throughput proteomics assay for target deconvolution. J. Proteome Res. 18, 4027\u20134037 https:\/\/doi.org\/10.1021\/acs.jproteome.9b00500 (2019).","journal-title":"J. Proteome Res."},{"key":"1736_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.2732","volume":"11","author":"RM Branca","year":"2014","unstructured":"Branca, R. M. et al. HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics. Nat. Methods 11, 59\u201362 https:\/\/doi.org\/10.1038\/nmeth.2732 (2014).","journal-title":"Nat. Methods"},{"key":"1736_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29224-5","volume":"13","author":"IR Leo","year":"2022","unstructured":"Leo, I. R. et al. Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines. Nat. Commun. 13, 1691 https:\/\/doi.org\/10.1038\/s41467-022-29224-5 (2022).","journal-title":"Nat. Commun."},{"key":"1736_CR33","doi-asserted-by":"publisher","first-page":"vbad143","DOI":"10.1093\/bioadv\/vbad143","volume":"3","author":"L Aswad","year":"2023","unstructured":"Aswad, L. & Jafari, R. FORALL: an interactive shiny\/R web portal to navigate multi-omics high-throughput data of pediatric acute lymphoblastic leukemia. Bioinform. Adv. 3, vbad143 https:\/\/doi.org\/10.1093\/bioadv\/vbad143 (2023).","journal-title":"Bioinform. Adv."},{"key":"1736_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","volume":"1","author":"SM Corsello","year":"2020","unstructured":"Corsello, S. M. et al. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat. Cancer 1, 235\u2013248 https:\/\/doi.org\/10.1038\/s43018-019-0018-6 (2020).","journal-title":"Nat. Cancer"},{"key":"1736_CR35","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero, T. et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat. Med. 13, 1203\u20131210 https:\/\/doi.org\/10.1038\/nm1636 (2007).","journal-title":"Nat. Med."},{"key":"1736_CR36","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/bioinformatics\/btx082","volume":"33","author":"C Hernandez-Armenta","year":"2017","unstructured":"Hernandez-Armenta, C., Ochoa, D., Goncalves, E., Saez-Rodriguez, J. & Beltrao, P. Benchmarking substrate-based kinase activity inference using phosphoproteomic data. Bioinformatics 33, 1845\u20131851 https:\/\/doi.org\/10.1093\/bioinformatics\/btx082 (2017).","journal-title":"Bioinformatics"},{"key":"1736_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2174\/1568009054629654","volume":"5","author":"M Lei","year":"2005","unstructured":"Lei, M. The MCM complex: its role in DNA replication and implications for cancer therapy. Curr. Cancer Drug Targets 5, 365\u2013380 https:\/\/doi.org\/10.2174\/1568009054629654 (2005).","journal-title":"Curr. Cancer Drug Targets"},{"key":"1736_CR38","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41580-025-00841-4","volume":"26","author":"R Ceccaldi","year":"2025","unstructured":"Ceccaldi, R. & Cejka, P. Mechanisms and regulation of DNA end resection in the maintenance of genome stability. Nat. Rev. Mol. Cell Biol. 26, 586\u2013599 https:\/\/doi.org\/10.1038\/s41580-025-00841-4 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1736_CR39","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner, W. M. et al. GammaH2AX and cancer. Nat. Rev. Cancer 8, 957\u2013967 https:\/\/doi.org\/10.1038\/nrc2523 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1736_CR40","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/S0021-9258(18)71857-7","volume":"252","author":"PG Plagemann","year":"1977","unstructured":"Plagemann, P. G. & Erbe, J. Exit transport of a cyclic nucleotide from mouse L-cells. J. Biol. Chem. 252, 2010\u20132016 (1977).","journal-title":"J. Biol. Chem."},{"key":"1736_CR41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41420-025-02683-7","volume":"11","author":"X Yan","year":"2025","unstructured":"Yan, X. & Liu, C. The ATF4-glutamine axis: a central node in cancer metabolism, stress adaptation, and therapeutic targeting. Cell Death Discov. 11, 390 https:\/\/doi.org\/10.1038\/s41420-025-02683-7 (2025).","journal-title":"Cell Death Discov."},{"key":"1736_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/cdd.2012.157","volume":"20","author":"I Ben-Sahra","year":"2013","unstructured":"Ben-Sahra, I. et al. Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death. Cell Death Differ. 20, 611\u2013619 https:\/\/doi.org\/10.1038\/cdd.2012.157 (2013).","journal-title":"Cell Death Differ."},{"key":"1736_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00528-7","volume":"8","author":"N Struyf","year":"2024","unstructured":"Struyf, N. et al. Delineating functional and molecular impact of ex vivo sample handling in precision medicine. NPJ Precis. Oncol. 8, 38 https:\/\/doi.org\/10.1038\/s41698-024-00528-7 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"1736_CR44","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1182\/blood-2022-163046","volume":"140","author":"T Erkers","year":"2022","unstructured":"Erkers, T. et al. Data-driven molecular hallmarks of acute myeloid leukemia: biological, prognostic and therapeutic implications. Blood 140, 6299\u20136299 https:\/\/doi.org\/10.1182\/blood-2022-163046 (2022).","journal-title":"Blood"},{"key":"1736_CR45","doi-asserted-by":"publisher","unstructured":"Struyf, N. et al. Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics. NPJ Precis. Oncol. https:\/\/doi.org\/10.1038\/s41698-026-01363-8 (2026).","DOI":"10.1038\/s41698-026-01363-8"},{"key":"1736_CR46","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1111\/bph.70215","volume":"182","author":"M Posta","year":"2025","unstructured":"Posta, M. & Gyorffy, B. Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets. Br. J. Pharm. 182, 5734\u20135747 https:\/\/doi.org\/10.1111\/bph.70215 (2025).","journal-title":"Br. J. Pharm."},{"key":"1736_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.12.006","volume":"172","author":"I Piazza","year":"2018","unstructured":"Piazza, I. et al. A map of protein-metabolite interactions reveals principles of chemical communication. Cell 172, 358\u2013372 e323 https:\/\/doi.org\/10.1016\/j.cell.2017.12.006 (2018).","journal-title":"Cell"},{"key":"1736_CR48","first-page":"3672","volume":"44","author":"PJ Basseches","year":"1984","unstructured":"Basseches, P. J. & Powis, G. Metabolism and disposition of 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene in the rat. Cancer Res. 44, 3672\u20133678 (1984).","journal-title":"Cancer Res."},{"key":"1736_CR49","doi-asserted-by":"publisher","unstructured":"Osa-Andrews, B., Tan, K. W., Sampson, A. & Iram, S. H. Development of novel intramolecular FRET-based ABC transporter biosensors to identify new substrates and modulators. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics10040186 (2018).","DOI":"10.3390\/pharmaceutics10040186"},{"key":"1736_CR50","doi-asserted-by":"publisher","first-page":"e21741","DOI":"10.1096\/fj.202100457RR","volume":"35","author":"O Goroshchuk","year":"2021","unstructured":"Goroshchuk, O. et al. Thermal proteome profiling identifies PIP4K2A and ZADH2 as off-targets of Polo-like kinase 1 inhibitor volasertib. FASEB J. 35, e21741 https:\/\/doi.org\/10.1096\/fj.202100457RR (2021).","journal-title":"FASEB J."},{"key":"1736_CR51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","volume":"14","author":"CS Hughes","year":"2019","unstructured":"Hughes, C. S. et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat. Protoc. 14, 68\u201385 https:\/\/doi.org\/10.1038\/s41596-018-0082-x (2019).","journal-title":"Nat. Protoc."},{"key":"1736_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-163","volume":"9","author":"M Sturm","year":"2008","unstructured":"Sturm, M. et al. OpenMS - an open-source software framework for mass spectrometry. BMC Bioinforma. 9, 163 https:\/\/doi.org\/10.1186\/1471-2105-9-163 (2008).","journal-title":"BMC Bioinforma."},{"key":"1736_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-026-01349-7","author":"Y Zhu","year":"2026","unstructured":"Zhu, Y. et al. Differential protein expression analysis of quantitative mass spectrometry data using DEqMS. Nat. Protoc. https:\/\/doi.org\/10.1038\/s41596-026-01349-7 (2026).","journal-title":"Nat. Protoc."},{"key":"1736_CR54","doi-asserted-by":"publisher","first-page":"10296","DOI":"10.1021\/ac5025842","volume":"86","author":"CJ Tape","year":"2014","unstructured":"Tape, C. J. et al. Reproducible automated phosphopeptide enrichment using magnetic TiO2 and Ti-IMAC. Anal. Chem. 86, 10296\u201310302 https:\/\/doi.org\/10.1021\/ac5025842 (2014).","journal-title":"Anal. Chem."},{"key":"1736_CR55","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1074\/mcp.TIR119.001646","volume":"19","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y. et al. DEqMS: a method for accurate variance estimation in differential protein expression analysis. Mol. Cell Proteom. 19, 1047\u20131057 https:\/\/doi.org\/10.1074\/mcp.TIR119.001646 (2020).","journal-title":"Mol. Cell Proteom."},{"key":"1736_CR56","doi-asserted-by":"publisher","unstructured":"Smyth, G. K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. https:\/\/doi.org\/10.2202\/1544-6115.1027 (2004).","DOI":"10.2202\/1544-6115.1027"},{"key":"1736_CR57","doi-asserted-by":"publisher","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","volume":"48","author":"A Ianevski","year":"2020","unstructured":"Ianevski, A., Giri, A. K. & Aittokallio, T. SynergyFinder 2.0: visual analytics of multi-drug combination synergies. Nucleic Acids Res. 48, W488\u2013W493 https:\/\/doi.org\/10.1093\/nar\/gkaa216 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1736_CR58","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1736_CR59","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 https:\/\/doi.org\/10.1093\/bioinformatics\/btr260 (2011).","journal-title":"Bioinformatics"},{"key":"1736_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinforma."},{"key":"1736_CR61","doi-asserted-by":"publisher","unstructured":"Kerseviciute, I. & Gordevicius, J. aPEAR: an R package for autonomous visualization of pathway enrichment networks. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/btad672 (2023).","DOI":"10.1093\/bioinformatics\/btad672"},{"key":"1736_CR62","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1093\/bioinformatics\/btx415","volume":"33","author":"DD Wiredja","year":"2017","unstructured":"Wiredja, D. D., Koyuturk, M. & Chance, M. R. The KSEA App: a web-based tool for kinase activity inference from quantitative phosphoproteomics. Bioinformatics 33, 3489\u20133491 https:\/\/doi.org\/10.1093\/bioinformatics\/btx415 (2017).","journal-title":"Bioinformatics"},{"key":"1736_CR63","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 https:\/\/doi.org\/10.1093\/nar\/gkae1011 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01736-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01736-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01736-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:36:52Z","timestamp":1792042612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01736-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01736-z","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"390"}}